Caspase activation in etoposide‐treated fibroblasts is correlated to ERK phosphorylation and both events are blocked by polyamine depletion

Authors:
  • BTBenedetta Tantini
    Benedetta Tantini
  • MFMonia Fattori
    Monia Fattori
  • ISIvana Stanic’
    Ivana Stanic’
  • CPCarla Pignatti
    Carla Pignatti
  • CCCarlo Clo
    Carlo Clo
  • CGCarlo Guarnieri
    Carlo Guarnieri
  • CCClaudio M Caldarera
    Claudio M Caldarera
  • CMCaroline A Mackintosh
    Caroline A Mackintosh
  • APAnthony E Pegg
    Anthony E Pegg
  • FFFlavio Flamigni
    Flavio Flamigni

Abstract
Activation of the extracellular signal‐regulated kinases (ERKs) 1 and 2 is correlated to cell survival, but in some cases ERKs can act in signal transduction pathways leading to apoptosis. Treatment of mouse fibroblasts with 20 μM etoposide elicited a sustained phosphorylation of ERK 1/2, that increased until 24 h from the treatment in parallel with caspase activity. The inhibitor of ERK activation PD98059 abolished caspase activation, but caspase inhibition did not reduce ERK 1/2 phosphorylation, suggesting that ERK activation is placed upstream of caspases. Both ERK and caspase activation were blocked in cells depleted of polyamines by the ornithine decarboxylase inhibitor α‐difluoromethylornithine (DFMO). In etoposide‐treated cells, DFMO also abolished phosphorylation of c‐Jun NH2‐terminal kinases triggered by the drug. Polyamine replenishment with exogenous putrescine restored the ability of the cells to undergo caspase activation and ERK 1/2 phosphorylation in response to etoposide. Ornithine decarboxylase activity decreased after etoposide, indicating that DFMO exerts its effect by depleting cellular polyamines before induction of apoptosis. These results reveal a role for polyamines in the transduction of the death signal triggered by etoposide.

This publication has 40 references indexed in Scilit: